Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Arcadia Biosciences (RKDA) Return on Equity (2016 - 2025)

Historic Return on Equity for Arcadia Biosciences (RKDA) over the last 11 years, with Q3 2025 value amounting to 0.01%.

  • Arcadia Biosciences' Return on Equity rose 4400.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 4400.0%. This contributed to the annual value of 0.29% for FY2024, which is 1800.0% up from last year.
  • Per Arcadia Biosciences' latest filing, its Return on Equity stood at 0.01% for Q3 2025, which was up 4400.0% from 0.07% recorded in Q2 2025.
  • In the past 5 years, Arcadia Biosciences' Return on Equity registered a high of 0.01% during Q3 2025, and its lowest value of 1.13% during Q1 2022.
  • In the last 5 years, Arcadia Biosciences' Return on Equity had a median value of 0.41% in 2021 and averaged 0.48%.
  • In the last 5 years, Arcadia Biosciences' Return on Equity skyrocketed by 26300bps in 2021 and then crashed by -7900bps in 2022.
  • Over the past 5 years, Arcadia Biosciences' Return on Equity (Quarter) stood at 1.0% in 2021, then surged by 56bps to 0.44% in 2022, then grew by 1bps to 0.44% in 2023, then rose by 25bps to 0.33% in 2024, then surged by 98bps to 0.01% in 2025.
  • Its Return on Equity stands at 0.01% for Q3 2025, versus 0.07% for Q2 2025 and 0.16% for Q1 2025.